Figure S1 from A Phase I Study of ASTX660, an Antagonist of Inhibitors of Apoptosis Proteins, in Adults with Advanced Cancers or Lymphoma
crossref（2023）
Abstract
Figure S1 shows ASTX660 dose proportionality-power model analyses on AUC0-24 and Cmax by formulation.
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined